Contact

Arovia Home About Services Legal Access Guide Medical Risks & Considerations Evidence & What Research Shows Contact Canada / access + safety / 2026 Ibogaine Clinic In Canada: What To Know First Ibogaine is experimental, medically complex, and not a substitute for careful addiction treatment. Start with the legal limits, the evidence, and the safety questions that cannot be skipped. Independent resource 01 / 06 A decision about ibogaine treatment should begin with risk, not promise. Serious cardiac complications, medication interactions, and unclear access rules make medical supervision central. Arovia is an independent resource on ibogaine access and safety in Canada. It does not provide treatment recommendations or clinical care. Legal clarity • Patient safety • Medical supervision • Evidence before claims • Legal clarity • Patient safety • Medical supervision • Evidence before claims 01 / Access Start with legality, not clinic marketing. Canadian access is narrow and uncertain Ibogaine is a naturally occurring psychoactive alkaloid associated with the iboga root, a plant medicine from West Africa. It is not approved as a pharmaceutical drug in Canada, and its legal status does not create a straightforward consumer market for ibogaine treatment. Descriptions of ibogaine treatment laws can conflict, so Canadian law should be assessed carefully rather than assumed from a retreat listing. The substance has been described as outside the Controlled Drugs and Substances Act schedules, yet sale, distribution, and authorization can still be restricted through other federal rules. Health Canada may consider Special Access Program requests for serious or life-threatening conditions where conventional options have failed. The official Special Access Program framework explains why this is a physician-led exception, not routine access to a treatment center. A clinic should be able to explain its regulatory framework plainly: whether it is operating under research protoc

Contact

A place for useful feedback.